☆ 4.7 Letter

Monoclonal antibodies against macrophage colony-stimulating factor diminish the number of circulating intermediate and nonclassical (CD14++CD16 +/CD14+CD16++) monocytes in rheumatoid arthritis patient

BLOOD (2012)

Related references

Note: Only part of the references are listed.

Article Immunology

Preparations of intravenous immunoglobulins diminish the number and proinflammatory response of CD14+CD16++ monocytes in common variable immunodeficiency (CVID) patients

Maciej Siedlar et al.

CLINICAL IMMUNOLOGY (2011)

Add to Collection

Article Hematology

An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation

Kelli P. A. MacDonald et al.

BLOOD (2010)

Add to Collection

Article Hematology

Nomenclature of monocytes and dendritic cells in blood

Loems Ziegler-Heitbrock et al.

BLOOD (2010)

Add to Collection

Article Hematology

Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects

XM Dai et al.

BLOOD (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.